NCT00906399 Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT00642902 A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) Status TERMINATED Phase PHASE2